Who Should Not Use Peptide Therapy

Most peptide marketing is written as if everyone is a candidate. Nobody is a candidate for everything. The most useful thing a clinician can do in a peptide consultation is often to recognize, early, the situations where a peptide is a poor idea, and say so before anyone has spent money.

This is not a list meant to scare anyone off. It is the list a careful clinician runs through in their head during every consultation, written down so you can run through it too. It is general information, not a personal assessment. Whether any of this applies to you is a conversation to have with a licensed clinician who knows your full history.

First, a necessary distinction

"Peptide" describes a type of molecule, not a type of treatment. Insulin is a peptide. So is semaglutide. So is BPC-157. They have almost nothing in common clinically, and lumping them together is where a lot of confusion starts.

That matters here in two ways.

FDA-approved peptide medicines have labeling that lists contraindications (situations where the drug should not be used) and warnings, based on clinical trial data and post-marketing experience. For those, the label is the starting point.

Unapproved peptides, including most of those discussed online, have no approved labeling. Nobody has done the trials that would produce a reliable list of who should avoid them. For those, the absence of a contraindication list does not mean nobody should avoid them. It means nobody knows exactly who should, so a clinician has to reason from the biology, from related approved drugs and from what little human data exists, and generally err toward caution.

Pregnancy, trying to conceive and breastfeeding

This is the clearest category. For unapproved peptides, there is no human safety data in pregnancy at all, and experimental exposure of a developing baby is not a reasonable trade for goals like recovery, body composition or skin quality.

Approved peptide medicines point the same way. Tesamorelin (Egrifta SV) is contraindicated in pregnancy; its labeling notes that modifying abdominal fat offers no benefit during pregnancy and could result in fetal harm. The Wegovy (semaglutide) prescribing information advises discontinuing at least two months before a planned pregnancy because semaglutide stays in the body for a long time.

If you are pregnant, planning to be in the coming months, or breastfeeding, most peptide therapy should wait. Tell your clinician even if it feels unrelated to what you came in for.

Active cancer, or a history of cancer

Several of the most popular peptides act, directly or indirectly, on growth pathways:

• Growth hormone-axis peptides, such as sermorelin, tesamorelin, CJC-1295 and ipamorelin, are designed to raise growth hormone and, with it, IGF-1, a growth factor. Tesamorelin's FDA labeling makes this explicit: it is contraindicated in active malignancy, any preexisting malignancy should be inactive and its treatment complete before starting, and it should be stopped if a cancer recurs.
• Peptides promoted for healing, such as BPC-157 and thymosin beta-4, are thought to work partly by promoting new blood vessel growth, a process tumors also use. There is no human evidence that they cause or accelerate cancer, and also no long-term human evidence that they do not.

That does not automatically rule out every peptide for everyone with any cancer history. A person treated for an early skin cancer years ago is in a different position from someone with active disease. But it does mean an oncology history deserves a detailed conversation, possibly with your oncologist, before anything designed to promote growth is on the table. We explain the specific cautions for GH-axis peptides in tesamorelin: the approved GHRH analogue and its limits.

Contraindications written into approved peptide labels

For FDA-approved peptide medicines, some groups are named directly. A few examples that come up often:

This table is illustrative, not complete. Every approved drug has fuller labeling with warnings beyond its contraindications, and labels are updated. The GLP-1 class has its own detailed list, covered in who should not take GLP-1 medications, and bremelanotide's approved use is narrower than many people assume, as we explain in PT-141 (bremelanotide): what it is approved for.

Other health situations that call for extra caution

Diabetes or impaired blood sugar control

Raising growth hormone tends to push blood sugar up. Tesamorelin's labeling warns that it may cause glucose intolerance or diabetes and calls for monitoring. For someone with diabetes or prediabetes, GH-axis peptides are a poor fit without careful thought, while other peptide medicines, such as GLP-1s, affect blood sugar in the opposite direction and interact with diabetes medications. Either way, it needs a plan.

Heart disease and high blood pressure

Some peptides raise blood pressure or heart rate, at least temporarily. Bremelanotide is contraindicated in uncontrolled hypertension and known cardiovascular disease, and melanotan II, an unapproved relative in the same melanocortin family, raises similar concerns. Fluid retention, a known effect of raising growth hormone, can also be a problem for people with heart failure.

Pituitary problems

Peptides that work by prompting the pituitary to release growth hormone need a functioning pituitary. In people whose pituitary has been damaged or removed, they are unlikely to work as intended, and tesamorelin is specifically contraindicated in that situation.

Kidney or liver disease

These organs clear many drugs from the body. When they are impaired, how long a peptide stays in the system and at what level can change. For unapproved peptides, nobody has studied this, which is a reason for caution rather than reassurance.

A history of significant allergic reactions

Peptides can trigger immune reactions, and FDA has flagged immunogenicity as a concern for several injected peptides, particularly when products contain impurities or aggregated peptide. Someone with a history of serious allergic reactions, or a previous reaction to a peptide medicine, needs that factored in.

A history of disordered eating

Medicines that powerfully reduce appetite, such as GLP-1s, need particular care in anyone with a current or past eating disorder. That is a conversation to have openly with your clinician.

Under 18

Adolescents are still growing, and their growth hormone and sex hormone systems are actively developing. Apart from specific FDA-approved uses managed by pediatric specialists, peptides marketed for performance, physique or recovery have no place in teenage care. The same is true of unapproved peptides bought online, which some young athletes encounter through social media.

Tested athletes and military service members

This group is ruled out not by health but by rules, and the rules are strict. The WADA Prohibited List bans many peptides at all times, including growth hormone-releasing hormone and its analogues (such as sermorelin, CJC-1295 and tesamorelin), growth hormone secretagogues (such as ipamorelin), and thymosin beta-4 and its derivatives (such as TB-500) under class S2, and non-approved substances such as BPC-157 under class S0. The Department of Defense also lists BPC-157 among prohibited dietary supplement ingredients.

A positive test is not excused by a prescription, a compounding pharmacy or a "research" label. If you compete under anti-doping rules or serve in the military, read peptides and drug testing: what athletes must know before considering anything.

People who are not a good fit for other reasons

Some reasons are not medical at all, but they matter just as much:

• Unwillingness to do labs or follow-up. Monitoring is part of responsible prescribing. If you want a peptide without baseline labs or check-ins, a careful clinic will decline.
• Plans to combine with self-sourced products. Adding a prescribed medication on top of unregulated vials bought online makes it impossible to know what is causing what.
• Expecting a peptide to replace the basics. Peptides do not substitute for sleep, nutrition, training and treating underlying conditions. When those are not in place, fixing them usually does more.
• An untreated underlying cause. Fatigue from untreated sleep apnea, thyroid disease or anemia needs that cause addressed, not masked. The lab work worth doing before peptide therapy is often where those causes turn up.

What to do if one of these applies to you

Being in one of these groups does not mean there is nothing to be done about the problem that brought you here. It usually means the path looks different: an FDA-approved option with known risks, a specialist referral, lab work to find a treatable cause, or a non-drug approach with good evidence.

That is the reasoning behind how we run our peptide therapy consultations. We start with your history and screen for exactly these issues before discussing any treatment, and we will tell you plainly if peptide therapy is not right for you. You can read what actually happens in a peptide consultation, or simply book a consultation when you are ready.

Common questions

Can I use peptides if I had cancer in the past?

It depends on the cancer, how long ago, the treatment and the specific peptide. Growth hormone-axis peptides and peptides thought to promote blood vessel growth warrant particular caution. Tesamorelin's label, for example, requires any prior malignancy to be inactive with treatment complete. Discuss it with your clinician and, ideally, your oncologist.

Are peptides safe during pregnancy?

Unapproved peptides have no human safety data in pregnancy, and several approved peptide medicines are contraindicated or should be stopped before a planned pregnancy. Most peptide therapy should be avoided while pregnant, trying to conceive or breastfeeding.

Can people with diabetes use peptides?

Some peptide medicines, including insulin and GLP-1s, are central to diabetes care. Others, particularly growth hormone-axis peptides, can worsen blood sugar control. Which applies depends entirely on the peptide, so this needs an individual assessment.

Can athletes use peptides if a doctor prescribes them?

A prescription does not override anti-doping rules. Many peptides are prohibited at all times under the WADA Code. Athletes subject to testing should check with USADA or their governing body, and Therapeutic Use Exemptions are granted only in limited circumstances.